Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Single Agent RAD001 in Patients with Colon Cancer and Activating Mutations in the PI3KCA Gene
2005-005738-11Phase 2Active
- Sponsor
- Unidad Integral de Investigación en Oncología
- Start
- Apr 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of everolimus in colorectal cancer (CRC), sponsored by Unidad Integral de Investigación en Oncología. Primary endpoints: Progression-free survival, Time to progression and 2 more. Started Apr 2006; status: active.
02
Drugs
everolimus
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2005-005738-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005738-11.